Viatris Inc. , a global healthcare company, today announced four recent regulatory milestones spanning across all stages of its global pipeline:Octreotide Acetate for Injectable Suspension: The U.S.

London dubstep don Mala returns to his own label Deep Medi Musik after almost a decade, with 'Militant Don'. The t ...

A “manipulative monster” with a history of violence against women “smiled directly” into his partner’s face as he held their ...

The sealed, specially-built boxes were lifted onto flat-bed trucks behind the building and transported to a ...

Dr. Deepa Aggarwal, senior consultant paediatrician, recently shared an informative video on rabies. In her video, she spoke ...

Reinsurer, Gen Re, released its Protection Pulse today, showing Q3 growth among most protection lines, with number of ...

An announcement from Pulse Biosciences ( ($PLSE) ) is now available. On December 18, 2025, Pulse Biosciences announced that the U.S. Food and Drug ...

The CP Daily News Ticker is a running list of all our news updated in real-time throughout the day. This is also the home to our ‘Bite-sized updates from around the world’, which previously featured ...

Here is a recap of what happened in the search forums today, through the eyes of the Search Engine Roundtable and other search forums on the web. Google Ads MMC accounts are starting to see channel ...

This weekend’s streaming picks across new movies and shows range from thrillers to comedies, including "Fallout," "Emily in ...

Health care executive coaches explain why leaders aren't feeling holly-jolly this year. Plus, Shiv Rao on Abridge's next moves.

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung ...